Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chiral drug mass spectrometry quantitative analysis method based on chemical derivatization reaction and spectral deformation quantitative analysis theory

A technology for quantitative analysis and chiral drugs, applied in the field of mass spectrometry quantitative analysis of chiral drugs, can solve the problems that quantitative analysis results are susceptible to experimental errors, background interference, etc., and achieve the effects of wide application range, simple use, and cost saving

Active Publication Date: 2018-08-31
HUNAN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although univariate nonlinear models may be derived from sound underlying assumptions, their univariate nature makes their quantitative results susceptible to experimental error and background noise

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chiral drug mass spectrometry quantitative analysis method based on chemical derivatization reaction and spectral deformation quantitative analysis theory
  • Chiral drug mass spectrometry quantitative analysis method based on chemical derivatization reaction and spectral deformation quantitative analysis theory
  • Chiral drug mass spectrometry quantitative analysis method based on chemical derivatization reaction and spectral deformation quantitative analysis theory

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0039] Quantitative detection of chiral propranolol in tablets by mass spectrometry based on chemical derivatization reaction and spectral deformation quantitative analysis theory

[0040] Propranolol (propranolol), as a traditional β-adrenoceptor blocker, is widely used in clinical treatment of arrhythmia and antihypertension. Propranolol has two optical isomers, R-type and S-type. These two enantiomers are mainly metabolized by cytochrome P450 in vivo, and there are differences in stereoselectivity. Animal experiments have shown that the S-enantiomer β-receptor blocking effect is about 100 times stronger than that of the R-enantiomer, and has a longer half-life in the blood. At the same time, R-propranolol has the function of suppressing libido and is a male contraceptive. Propranolol has always been administered in the form of racemate in clinical practice. Since the activities of the two isomers are very different, it is of great significance to develop a simple and prac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
recovery rateaaaaaaaaaa
Login to View More

Abstract

The invention provides a chiral drug mass spectrometry quantitative analysis method based on a chemical derivatization reaction and spectral deformation quantitative analysis theory, and the main process is as follows: 1) preparing a chiral acyl chloride probe capable of reacting with a chiral drug by an organic synthesis reaction; 2) using the chiral probe to react with the chiral drug to producea diastereomer complex product; 3) using mass spectrometry to determine the mass spectral data of each fragment ion of the diastereomer complex product; 4) using the spectral deformation quantitativeanalysis theory to extract quantitative information of a target components in the chiral drug from the mass spectral data of the diastereomer complex product. The chiral drug mass spectrometry quantitative analysis method is suitable for quantitative analysis of nitrogen, sulfur or phosphorus-containing chiral drugs without using a chromatography column, and provides a simple, low-cost, sensitiveand accurate chiral drug detection method in the medical field.

Description

technical field [0001] The invention relates to an accurate quantitative analysis technology for mass spectrometry of chiral drugs in medical samples. In particular, it relates to a chiral drug mass spectrum quantitative analysis method based on chemical derivation reaction and spectral deformation analysis quantitative theory. technical background [0002] About more than half of the currently used drugs are chiral compounds, and nearly 90% of them are racemic drugs formed by the equimolar mixture of two enantiomers. The chirality of drug molecules has a great impact on the biological and pharmacological properties of drugs. The isomers of most chiral drugs have significant differences in biological activities such as pharmacology, toxicology, pharmacokinetics, and metabolism. For example, R-type thalidomide has a sedative effect, but S-type thalidomide has serious teratogenic effects, which caused numerous miscarriages and more than 12,000 "seal fetuses" between 1957 and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N27/62
CPCG01N27/62
Inventor 陈增萍朱艳丽
Owner HUNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products